The preclinical journey: transitioning a novel cell therapy into early phase clinical trials
Cell & Gene Therapy Insights 2024; 10(2), 171–177
DOI: 10.18609/cgti.2024.024
Published: 6 March
Interview
Silvio Manfredo-Vieira
Abi Pinchbeck, Commissioning Editor, Cell & Gene Therapy Insights, speaks toSilvio Manfredo-Vieira, Associate Director for Correlative and Translational Studies at the Department of Dermatology, University of Pennsylvania, about his role directing the translational research to move novel cell therapies from the lab into early phase clinical trials and pioneering a chimeric auto-antibody receptor to target B-cell-mediated diseases.